研究园简易版
·
经典书籍
·
期刊文章
·
有原文
·
完整版(可多选筛选、搜索)
·
首页
搜索
2021 年 · Diagnostics & Prediction(诊断与预测)
59 篇,新的在前。点标题看作者和摘要。
回到 2021 年
A Repeated Measures Approach to Pooled and Calibrated Biomarker Data
· Biometrics · 2021-12-30 · 在第 1 页
Minimum sample size calculations for external validation of a clinical prediction model with a time‐to‐event outcome
· SiM · 2021-12-16 · 在第 1 页
Covariate adjustment in continuous biomarker assessment
· Biometrics · 2021-12-14 · 在第 2 页
Risk prediction models for discrete ordinal outcomes: Calibration and the impact of the proportional odds assumption
· SiM · 2021-12-12 · 在第 2 页
Improving Trial Generalizability Using Observational Studies
· Biometrics · 2021-12-04 · 在第 2 页
Extending Hui‐Walter framework to correlated outcomes with application to diagnosis tests of an eye disease among premature infants
· SiM · 2021-12-03 · 在第 3 页
Reinforced Risk Prediction With Budget Constraint Using Irregularly Measured Data From Electronic Health Records
· JASA · 2021-11-30 · 在第 3 页
Optimal Simulator Selection
· JASA · 2021-11-30 · 在第 3 页
BIPSE: A biomarker‐based phase I/II design for immunotherapy trials with progression‐free survival endpoint
· SiM · 2021-11-25 · 在第 4 页
Risk prediction with imperfect survival outcome information from electronic health records
· Biometrics · 2021-11-22 · 在第 4 页
Robust and flexible inference for the covariate‐specific receiver operating characteristic curve
· SiM · 2021-11-20 · 在第 4 页
Dynamic logistic state space prediction model for clinical decision making
· Biometrics · 2021-11-15 · 在第 5 页
A smoothed corrected score approach for proportional hazards model with misclassified discretized covariates induced by error‐contaminated continuous time‐dependent exposure
· Biometrics · 2021-11-15 · 在第 5 页
Joint inference about the AUC and Youden index for paired biomarkers
· SiM · 2021-10-12 · 在第 7 页
Developing clinical prediction models when adhering to minimum sample size recommendations: The importance of quantifying bootstrap variability in tuning parameters and predictive performance
· SMMR · 2021-10-08 · 在第 7 页
Inference for a two-stage enrichment design
· AoS · 2021-10-01 · 在第 8 页
Integration of survival data from multiple studies
· Biometrics · 2021-09-16 · 在第 9 页
Incorporating baseline covariates to validate surrogate endpoints with a constant biomarker under control arm
· SiM · 2021-09-15 · 在第 9 页
Bayesian adaptive trial design for a continuous biomarker with possibly nonlinear or nonmonotone prognostic or predictive effects
· Biometrics · 2021-09-07 · 在第 10 页
Penalized regression calibration: A method for the prediction of survival outcomes using complex longitudinal and high‐dimensional data
· SiM · 2021-08-31 · 在第 11 页
Re‐calibrating pure risk integrating individual data from two‐phase studies with external summary statistics
· Biometrics · 2021-08-27 · 在第 11 页
Using knockoffs for controlled predictive biomarker identification
· SiM · 2021-07-30 · 在第 13 页
Confidence intervals of prediction accuracy measures for multivariable prediction models based on the bootstrap‐based optimism correction methods
· SiM · 2021-07-24 · 在第 13 页
Statistical methods for analysis of combined biomarker data from multiple nested case–control studies
· SMMR · 2021-07-07 · 在第 14 页
On the time‐varying predictive performance of longitudinal biomarkers: Measure and estimation
· SiM · 2021-06-22 · 在第 15 页
A copula‐based approach for dynamic prediction of survival with a binary time‐dependent covariate
· SiM · 2021-06-14 · 在第 16 页
Estimation and construction of confidence intervals for biomarker cutoff‐points under the shortest Euclidean distance from the ROC surface to the perfection corner
· SiM · 2021-06-03 · 在第 17 页
E-values: Calibration, combination and applications
· AoS · 2021-06-01 · 在第 17 页
A ROC‐based test for evaluating the group difference with an application to neonatal audiology screening
· SiM · 2021-05-29 · 在第 18 页
A two‐stage prediction model for heterogeneous effects of treatments
· SiM · 2021-05-27 · 在第 18 页
Minimum sample size for external validation of a clinical prediction model with a binary outcome
· SiM · 2021-05-24 · 在第 18 页
Efficient study design to estimate population means with multiple measurement instruments
· SiM · 2021-05-20 · 在第 18 页
Backward joint model and dynamic prediction of survival with multivariate longitudinal data
· SiM · 2021-05-20 · 在第 18 页
Measuring rater bias in diagnostic tests with ordinal ratings
· SiM · 2021-05-09 · 在第 19 页
Developing more generalizable prediction models from pooled studies and large clustered data sets
· SiM · 2021-05-05 · 在第 19 页
Biomarker evaluation under imperfect nested case‐control design
· SiM · 2021-04-29 · 在第 20 页
Confidence interval estimation for sensitivity and difference between two sensitivities at a given specificity under tree ordering
· SiM · 2021-04-27 · 在第 20 页
Biomarker‐guided heterogeneity analysis of genetic regulations via multivariate sparse fusion
· SiM · 2021-04-27 · 在第 20 页
Risk Projection for Time-to-Event Outcome Leveraging Summary Statistics With Source Individual-Level Data
· JASA · 2021-04-22 · 在第 21 页
Estimation of required sample size for external validation of risk models for binary outcomes
· SMMR · 2021-04-21 · 在第 21 页
Selection of within‐run quality control rules for laboratory biomarkers
· SiM · 2021-04-19 · 在第 21 页
Calibration of surgical tools using multilevel modeling with LINEX loss function: Theory and experiment
· SMMR · 2021-04-13 · 在第 21 页
Evaluation of predictive model performance of an existing model in the presence of missing data
· SiM · 2021-04-11 · 在第 22 页
A conditional approach for the receiver operating characteristic curve construction to evaluate diagnostic test performance in a family-matched case–control design
· SMMR · 2021-04-07 · 在第 22 页
Combined assessment of early and late‐phase outcomes in orphan drug development
· SiM · 2021-04-04 · 在第 22 页
Non-monotone transformation of biomarkers
· SMMR · 2021-03-29 · 在第 23 页
Semiparametric estimation of the nonmixture cure model with auxiliary survival information
· Biometrics · 2021-03-26 · 在第 23 页
Individual participant data meta‐analysis for external validation, recalibration, and updating of a flexible parametric prognostic model
· SiM · 2021-03-26 · 在第 23 页
Hierarchical Bayesian clustering design of multiple biomarker subgroups (HCOMBS)
· SiM · 2021-03-26 · 在第 23 页
On the design and the analysis of stratified biomarker trials in the presence of measurement error
· SiM · 2021-03-16 · 在第 24 页
Clinical prediction models to predict the risk of multiple binary outcomes: Methodological issues
· SiM · 2021-03-09 · 在第 24 页
Incorporating the dilution effect in group testing regression
· SiM · 2021-02-17 · 在第 25 页
Hybrid design evaluating new biomarkers when there is an existing screening test
· SiM · 2021-02-04 · 在第 27 页
The length of the receiver operating characteristic curve and the two cutoff Youden index within a robust framework for discovery, evaluation, and cutoff estimation in biomarker studies involving improper receiver operating characteristic curves
· SiM · 2021-02-02 · 在第 27 页
Combining multiple biomarkers to linearly maximize the diagnostic accuracy under ordered multi-class setting
· SMMR · 2021-02-01 · 在第 28 页
Two‐stage penalized regression screening to detect biomarker–treatment interactions in randomized clinical trials
· Biometrics · 2021-01-29 · 在第 28 页
Dynamic prediction of disease processes based on recurrent history and functional principal component analysis of longitudinal biomarkers: Application for ovarian epithelial cancer
· SiM · 2021-01-22 · 在第 28 页
The optimal design of clinical trials with potential biomarker effects: A novel computational approach
· SiM · 2021-01-11 · 在第 29 页
Stochastic Proximal AUC Maximization
· JMLR · 2021 · 在第 31 页